ClinicalTrials.govpublic full text
Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors
locally advanced and metastatic solid tumors, bgb-a1217, anti-tigit antibody, tislelizumab, anti-pd-1 antibody, ociperlimab, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 874942
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.